Masato Maruyama

Masato Maruyama

Auto-generated profile, based on publicly available information

Masato Maruyama

Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushima-naka, Kita-ku, Okayama 700-8530, Japan

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
MMMasato Maruyama
Masato Maruyama
HTHaruka Tojo
Haruka Tojo
KTKeita Toi
Keita Toi
YIYusuke Ienaka
Yusuke Ienaka
KHKenji Hyodo
Kenji Hyodo
KHKazutaka Higaki
Kazutaka Higaki

1 December 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MMMasato Maruyama
Masato Maruyama
NANaomi Arisaka
Naomi Arisaka
YGYoshikuni Goto
Yoshikuni Goto
YOYosuke Ohsawa
Yosuke Ohsawa
HIHideshi Inoue
Hideshi Inoue
MTMasafumi Tsujimoto
Masafumi Tsujimoto
Human laeverin/aminopeptidase Q (LVRN/APQ) is a novel member of the M1 family of zinc aminopeptidases and is specifically expressed on the cell surface of human extravillous trophoblasts. Multiple sequence alignment of human M1 aminopeptidase revealed that the first Gly residue within the conserved exopeptidase motif of the M1 family, GXMEN motif, is uniquely substituted for His in human LVRN/APQ. In this study, we evaluated the roles of nonconserved His(379), comprising the exopeptidase motif in the enzymatic properties of human LVRN/APQ. We revealed that the substitution of His(379) with Gly caused significant changes in substrate specificity both toward fluorogenic substrates and natural peptide hormones. In addition, the susceptibilities of bestatin, a sensitive inhibitor for human LVRN/APQ, and natural inhibitory peptides were decreased in the H379G mutant. A molecular model suggested a conformational difference between wild-type and H379G human LVRN/APQs. These results indicate that His(379) of the enzyme plays essential roles in its distinctive enzymatic properties and contributes to maintaining the appropriate structure of the catalytic cavity of the enzyme. Our data may bring new insight into the biological significance of the unique exopeptidase motif of LVRN/APQ obtained during the evolution of primates.

1 December 2021 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
HMHironori Mukai
Hironori Mukai
MTMasashi Takanashi
Masashi Takanashi
KOKen-Ichi Ogawara
Ken-Ichi Ogawara
MMMasato Maruyama
Masato Maruyama
KHKazutaka Higaki
Kazutaka Higaki

6 February 2025 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
MMMasato Maruyama
Masato Maruyama
RTReiya Torii
Reiya Torii
HMHazuki Matsui
Hazuki Matsui
HHHiroki Hayashi
Hiroki Hayashi
KOKenichi Ogawara
Kenichi Ogawara
KHKazutaka Higaki
Kazutaka Higaki

11 March 2025 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SNSaki Nishiyama
Saki Nishiyama
YTYuki Takemoto
Yuki Takemoto
KYKeita Yamanouchi
Keita Yamanouchi
KKKeiji Kondo
Keiji Kondo
SKSho Kawatsu
Sho Kawatsu
KHKazutaka Higaki
Kazutaka Higaki

19 November 2023 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
HMHironori Mukai
Hironori Mukai
MTMasashi Takanashi
Masashi Takanashi
KOKenichi Ogawara
Kenichi Ogawara
MMMasato Maruyama
Masato Maruyama
KHKazutaka Higaki
Kazutaka Higaki